eVasc Neurovascular Enterprises
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
107 1099 8th Ave W, Vancouver, British C...Phone Number
(604) 742-3811Website
www.evasc.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About eVasc Neurovascular Enterprises
eCLIPs specializes in innovative medical devices for the endovascular repair of cerebral aneurysms, offering a higher standard of care and improved treatment outcomes. Their products are designed to effectively treat 95% of cerebral aneurysms, particularly targeting challenging wide-neck bifurcations. The devices feature a unique neck bridging design that promotes flow diversion and endothelial growth while ensuring ease of use. eCLIPs aims to provide effective solutions for healthcare professionals dealing with complex aneurysm cases.Explore more
eVasc Neurovascular Enterprises Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is eVasc Neurovascular Enterprises your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once eVasc Neurovascular Enterprises has new funding data
Website visits: Recent activity has been detected on your website
Check if eVasc Neurovascular Enterprises has recently received funding, and reach out quickly before it becomes old news!
eVasc Neurovascular Enterprises, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on eVasc Neurovascular Enterprises recently announced quarterly report
Click to see if eVasc Neurovascular Enterprises had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at eVasc Neurovascular Enterprises
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if eVasc Neurovascular Enterprises is spiking on competitors!
Product Launch: Get notified when eVasc Neurovascular Enterprises launches new products
Recommended Actions
Reach out to Masked Content who joined eVasc Neurovascular Enterprises as Masked Content
Find 2 more new buyers
Compare Similar Companies to eVasc Neurovascular Enterprises
Compare insights from companies similar to eVasc Neurovascular Enterprises, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
eVasc Neurovascular Enterprises is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
eVasc Neurovascular Enterprises is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about eVasc Neurovascular Enterprises.
eVasc Neurovascular Enterprises financials insights
Gather financial insights about eVasc Neurovascular Enterprises, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$7.6M
eVasc Neurovascular Enterprises Tech Stack
eVasc Neurovascular Enterprises News & Media
Evasc Neurovascular maakt inschrijving bekend van eerste patiënt in de Franse veiligheids-, haalbaarheids- en werkzaamheidsonderzoek eCLIPs™ (EESIS-FR)
VANCOUVER, British Columbia--(BUSINESS WIRE)--Evasc Neurovascular, een pionier op het gebied van de ontwikkeling van revolutionaire endovasculaire behandelingen voor hersenaneurysma's, heeft vandaag de inschrijving bekendgemaakt van de eerste patiënt in het Franse veiligheids-, haalbaarheids- en werkzaamheidsonderzoek eCLIPs™ (EESIS-FR). Het onderzoek wordt in Frankrijk uitgevoerd met als doel de technische haalbaarheid, veiligheid en werkzaamheid van de eCLIPs-producten voor de behandeling vanEvasc Neurovascular annuncia l'arruolamento del primo paziente nello studio francese di sicurezza, fattibilità ed efficacia (EESIS-FR) eCLIPs™
VANCOUVER, Columbia Britannica--(BUSINESS WIRE)--Evasc Neurovascular, un pioniere nello sviluppo di innovativi trattamenti endovascolari per gli aneurismi cerebrali, oggi ha annunciato l'arruolamento del primo paziente nel suo studio francese di sicurezza, fattibilità ed efficacia (EESIS-FR) eCLIPs™. Lo studio si svolgerà in Francia e valuterà la fattibilità tecnica, la sicurezza e l'efficacia dei prodotti eCLIPs nel trattamento degli aneurismi a livello delle biforcazioni. Il dispositivo eCLIPEvasc Neurovascular anuncia la inscripción del primer paciente en el estudio francés eCLIPs™ de seguridad, viabilidad y eficacia (EESIS-FR)
VANCOUVER, Columbia Británica--(BUSINESS WIRE)--Evasc Neurovascular, pionera en el desarrollo de tratamientos endovasculares revolucionarios para aneurismas cerebrales, ha anunciado hoy la inscripción del primer paciente en su estudio francés de seguridad, viabilidad y eficacia de eCLIPs™ (EESIS-FR). El estudio se realizará en Francia con el objetivo de evaluar la viabilidad técnica, la seguridad y la eficacia de los productos eCLIPs para el tratamiento de aneurismas de bifurcación. El dispositEvasc Neurovascular meldet Aufnahme des ersten Patienten in die französische Sicherheits-, Machbarkeits- und Wirksamkeitsstudie (EESIS-FR) zu eCLIPs™
VANCOUVER, British Columbia--(BUSINESS WIRE)--Evasc Neurovascular, ein Vorreiter in der Entwicklung bahnbrechender endovaskulärer Therapien für zerebrale Aneurysmen, meldete heute, dass der erste Patient in seine französische Sicherheits-, Machbarkeits- und Wirksamkeitsstudie (EESIS-FR) zu eCLIPs™ aufgenommen wurde. Die Studie wird in Frankreich durchgeführt und soll die technische Machbarkeit, Sicherheit und Wirksamkeit der eCLIPs-Produkte bei der Behandlung von Bifurkationsaneurysmen bewerten
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding eVasc Neurovascular Enterprises
Sign Up For FreeTo access detailed company insights
eCLIPs specializes in innovative medical devices for the endovascular repair of cerebral aneurysms, offering a higher standard of care and improved treatment outcomes. Their products are designed to effectively treat 95% of cerebral aneurysms, particularly targeting challenging wide-neck bifurcations. The devices feature a unique neck bridging desi... Read More
